This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, Q. T. Articles by Marlan AJ$[corrected to Marian, A. Search for Related Content PubMed PubMed Citation Articles by Yu, Q. T. Articles by Marlan AJ$[corrected to Marian, A.

Circulation, Vol 87, 406-412, Copyright © 1993 by American Heart Association

ARTICLES

Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle [published errata appear in Circulation 1993 May;87(5):1775 and 1993 Jun;87(6):2070]

QT Yu, J Ifegwu, AJ Marian, A Mares Jr, R Hill, MB Perryman, LL Bachinski, R Roberts and AJ] Marlan AJ$[corrected to Marian
Baylor College of Medicine, Houston, TX 77030.

BACKGROUND. The beta-myosin heavy chain (beta-MHC) gene has been identified as a major locus for familial hypertrophic cardiomyopathy (FHCM). We recently showed that one of the common mutations associated with FHCM is expressed in the cardiac muscle messenger RNA (mRNA) of an affected individual. Since beta-MHC is a major sarcomeric protein of cardiac and skeletal muscle, studies were performed to determine whether the mutation is also expressed in skeletal muscle. METHODS AND RESULTS. Biopsies were obtained of skeletal muscle (biceps brachii) from a proband with FHCM known to have the missense mutation in exon 13 of the beta-MHC gene. RNA was extracted from skeletal muscle and lymphocytes by the RNAzol method. First-strand complementary DNA was synthesized by reverse transcription using an antisense primer to exon 16. Polymerase chain reaction (PCR) was performed using primers to exons 12 and 14 to amplify the segment encompassing exon 13. The PCR products were digested with Ddel restriction endonuclease. Undigested PCR product in the control and the proband was 321 base-pairs (bp). Ddel digestion of the PCR product from normal skeletal and lymphocytes showed two DNA fragments of 181 and 140 bp as expected, whereas digestion of the PCR product from the proband's skeletal muscle and lymphocytes showed four DNA fragments of 181, 149, 140, and 32 bp due to the mutation in exon 13. This indicates that the mutation in affected individuals is also expressed in the mRNA of skeletal muscle and lymphocytes. CONCLUSIONS. To our knowledge, this is the first documentation of a beta-MHC gene mutation expressed in skeletal muscle. This finding is provocative. Does it impair skeletal muscle function? If so, how? If not, why not? Is the impairment, or lack of it, a clue to the molecular defect of cardiac muscle? Furthermore, skeletal muscle provides a readily accessible source of mRNA for expression studies and for purification of the beta-MHC protein, which is probably essential to future investigation designed to unravel the molecular basis of this disorder.

This article has been cited by other articles:

				S. E. Kirschner, E. Becker, M. Antognozzi, H.-P. Kubis, A. Francino, F. Navarro-Lopez, N. Bit-Avragim, A. Perrot, M. M. Mirrakhimov, K.-J. Osterziel, et al. Hypertrophic cardiomyopathy-related {beta}-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1242 - H1251. [Abstract] [Full Text] [PDF]

				R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part I Circulation, October 23, 2001; 104(17): 2113 - 2116. [Full Text] [PDF]

				R. Bottinelli, D. A. Coviello, C. S. Redwood, M. A. Pellegrino, B. J. Maron, P. Spirito, H. Watkins, and C. Reggiani A Mutant Tropomyosin That Causes Hypertrophic Cardiomyopathy Is Expressed In Vivo and Associated With an Increased Calcium Sensitivity Circ. Res., January 23, 1998; 82(1): 106 - 115. [Abstract] [Full Text] [PDF]

				A.J. Marian and R. Roberts Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy Circulation, September 1, 1995; 92(5): 1336 - 1347. [Full Text]

				A. J. Marian, Q.-T. Yu, D. L. Mann, F. L. Graham, and R. Roberts Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes Circ. Res., July 1, 1995; 77(1): 98 - 106. [Abstract] [Full Text]

				H. Nishi, A. Kimura, H. Harada, Y. Koga, K. Adachi, K. Matsuyama, T. Koyanagi, S. Yasunaga, T. Imaizumi, H. Toshima, et al. A Myosin Missense Mutation, Not A Null Allele, Causes Familial Hypertrophic Cardiomyopathy Circulation, June 15, 1995; 91(12): 2911 - 2915. [Abstract] [Full Text]

				K. Schwartz, L. Carrier, P. Guicheney, and M. Komajda Molecular Basis of Familial Cardiomyopathies Circulation, January 15, 1995; 91(2): 532 - 540. [Full Text]